Learn More
Medchemexpress LLC NTRC 0066-0 | 1817791-73-3 | 99.01% | 565.71 | 5 MG

Supplier: Medchemexpress LLC 5MGHY100024
NTRC 0066-0 is a selective threonine tyrosine kinase (TTK) inhibitor, demonstrating potent anti-proliferative activity against diverse cancer cell lines. With an IC50 of 0.9 nM, it is utilized in cancer research, exhibiting low selectivity entropy and a prolonged target residence time on TTK.
- Selective threonine tyrosine kinase (TTK) inhibitor (IC50=0.9 nM).
- Used for cancer research.
- Exhibits low selectivity entropy.
- Relatively long target residence time on TTK.
- Inhibits proliferation of diverse cancer cell lines with potency similar to classic chemotherapeutic agents.
- Demonstrates subnanomolar potency in a TTK enzyme assay.
- Inhibits tumor growth in a mouse xenograft model of human triple-negative breast cancer (TNBC).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.